Scientists found that a rare form of liver cancer evades the immune system by luring T-cells into surrounding fibrous tissue where they become inactive and ineffective.
Tag: amd3100
FDA-Approved Drug AMD3100 May Help Immunotherapy Defeat Rare Liver Cancer by Freeing Trapped T Cells
Researchers found AMD3100 releases T cells from fibrous tissue surrounding tumors enabling immune system to attack cancer cells.